Rajesh Dikshit

Rajesh Dikshit

Auto-generated profile, based on publicly available information

Rajesh Dikshit

Tata Memorial Centre

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2021 in BMJ
Verified
Journal Article
Open access
PDF file
IMIndraneel Mittra
Indraneel Mittra
GMGauravi A Mishra
Gauravi A Mishra
RDRajesh P Dikshit
Rajesh P Dikshit
SGSubhadra Gupta
Subhadra Gupta
VKVasundhara Y Kulkarni
Vasundhara Y Kulkarni
RBRajendra A Badwe
Rajendra A Badwe
Objective: To test the efficacy of screening by clinical breast examination in downstaging breast cancer at diagnosis and in reducing mortality from the disease, when compared with no screening.Design: Prospective, cluster randomised controlled trial.Setting: 20 geographically distinct clusters located in Mumbai, India, randomly allocated to 10 screening and 10 control clusters; total trial duration was 20 years (recruitment began in May 1998; database locked in March 2019 for analysis).Participants: 151 538 women aged 35-64 with no history of breast cancer.Interventions: Women in the screening arm (n=75 360) received four screening rounds of clinical breast examination (conducted by trained female primary health workers) and cancer awareness every two years, followed by five rounds of active surveillance every two years. Women in the control arm (n=76 178) received one round of cancer awareness followed by eight rounds of active surveillance every two years.Main outcome measures: Downstaging of breast cancer at diagnosis and reduction in mortality from breast cancer.Results: Breast cancer was detected at an earlier age in the screening group than in the control group (age 55.18 (standard deviation 9.10)v56.50 (9.10); P=0.01), with a significant reduction in the proportion of women with stage III or IV disease (37% (n=220)v47% (n=271), P=0.001). A non-significant 15% reduction in breast cancer mortality was observed in the screening arm versus control arm in the overall study population (age 35-64; 20.82 deaths per 100 000 person years (95% confidence interval 18.25 to 23.97)v24.62 (21.71 to 28.04); rate ratio 0.85 (95% confidence interval 0.71 to 1.01); P=0.07). However, a post hoc subset analysis showed nearly 30% relative reduction in breast cancer mortality in women aged 50 and older (24.62 (20.62 to 29.76)v34.68 (27.54 to 44.37); 0.71 (0.54 to 0.94); P=0.02), but no significant reduction in women younger than 50 (19.53 (17.24 to 22.29)v21.03 (18.97 to 23.44); 0.93 (0.79 to 1.09); P=0.37). A 5% reduction in all cause mortality was seen in the screening arm versus the control arm, but it was not statistically significant (rate ratio 0.95 (95% confidence interval 0.81 to 1.10); P=0.49).Conclusions: These results indicate that clinical breast examination conducted every two years by primary health workers significantly downstaged breast cancer at diagnosis and led to a non-significant 15% reduction in breast cancer mortality overall (but a significant reduction of nearly 30%in mortality in women aged ≥50). No significant reduction in mortality was seen in women younger than 50 years. Clinical breast examination should be considered for breast cancer screening in low and middle income countries.Trial registration: Clinical Trials Registry of India CTRI/2010/091/001205; ClinicalTrials.govNCT00632047.

1 January 2011 in Indian Journal of Medical and Paediatric Oncology
Verified
Journal Article
Open access
PDF file
RDRajesh P Dikshit
Rajesh P Dikshit
GMGarima Mathur
Garima Mathur
SMSharayu Mhatre
Sharayu Mhatre
BYB B Yeole
B B Yeole
Stomach cancer is the one of the leading cause of cancer in southern region of India. Its incidence is decreasing worldwide yet on global scale stomach cancer remains one of the most common causes of cancer death. Etiology of gastric cancer includes Helicobacter pylori infection, diet and lifestyle, tobacco, alcohol and genetic susceptibility. In this review, we tried to find the contribution of Indian scientist in understanding the descriptive and observational epidemiology of stomach cancer. PubMed was used as a search platform using key words such as "stomach cancer, treatment, clinical characteristics, stomach cancer outcome, epidemiology, etiological factor and their corresponding Mesh terms were used in combination with Boolean operators OR, AND". Most of the reported studies on gastric cancer from India are case report or case series and few are case-control studies. Indian studies on this topic are limited and have observed H. pylori infection, salted tea, pickled food, rice intake, spicy food, soda (additive of food), tobacco and alcohol as risk factors for gastric cancer. More research is required to understand the etiology, develop suitable screening test, to demarcate high-risk population and to develop and evaluate the effect of primary prevention programs.

1 April 2017 in The Lancet Oncology
Verified
Journal Article
Closed access
SMSharayu Mhatre
Sharayu Mhatre
ZWZhaoming Wang
Zhaoming Wang
RNRajini Nagrani
Rajini Nagrani
RBRajendra Badwe
Rajendra Badwe
SCShubhada Chiplunkar
Shubhada Chiplunkar
PRPreetha Rajaraman
Preetha Rajaraman

1 October 2016 in European Journal of Cancer
Verified
Journal Article
Open access
RNR. Nagrani
R. Nagrani
SMS. Mhatre
S. Mhatre
PRP. Rajaraman
P. Rajaraman
ISI. Soerjomataram
I. Soerjomataram
PBP. Boffetta
P. Boffetta
RDR. Dikshit
R. Dikshit
Current evidence suggests that the relationship between obesity and breast cancer (BC) risk may vary between ethnic groups. A total of 1633 BC cases and 1504 controls were enrolled in hospital-based case-control study in Mumbai, India, from 2009 to 2013. Along with detailed questionnaire, we collected anthropometric measurements on all participants. We used unconditional logistic regression models to estimate odds ratios (ORs) and 95% confidence interval (CI) for BC risk associated with anthropometry measurements, stratified on tumour subtype and menopausal status. Waist-to-hip ratio (WHR) of ≥0.95 was strongly associated with risk of BC compared to WHR ≤0.84 in both premenopausal (OR = 4.3; 95% CI: 2.9-6.3) and postmenopausal women (OR = 3.4; 95% CI: 2.4-4.8) after adjustment for body mass index (BMI). Premenopausal women with a BMI ≥30 were at lower risk compared to women with normal BMI (OR = 0.5; 95% CI: 0.4-0.8). A similar protective effect was observed in women who were postmenopausal for <10 years (OR = 0.6; 95% CI: 0.4-0.9) but not in women who were postmenopausal for ≥10 years (OR = 1.8; 95% CI: 1.1-3.3). Overweight and obese women (BMI: 25-29.9 and ≥ 30 kg/m(2), respectively) were at increased BC risk irrespective of menopausal status if their WHR ≥0.95. Central obesity (measured in terms of WC and WHR) increased the risk of both premenopausal and postmenopausal BCs irrespective of hormone receptor (HR) status. Central obesity appears to be a key risk factor for BC irrespective of menopausal or HR status in Indian women with no history of hormone replacement therapy.

4 February 2014 in BMC Medicine
Verified
Journal Article
Open access
PDF file
LALukasz Aleksandrowicz
Lukasz Aleksandrowicz
VMVarun Malhotra
Varun Malhotra
RDRajesh Dikshit
Rajesh Dikshit
PGPrakash C Gupta
Prakash C Gupta
RKRajesh Kumar
Rajesh Kumar
PJPrabhat Jha
Prabhat Jha
Background: Verbal autopsy (VA) has been proposed to determine the cause of death (COD) distributions in settings where most deaths occur without medical attention or certification. We develop performance criteria for VA-based COD systems and apply these to the Registrar General of India’s ongoing, nationally-representative Indian Million Death Study (MDS). Methods: Performance criteria include a low ill-defined proportion of deaths before old age; reproducibility, including consistency of COD distributions with independent resampling; differences in COD distribution of hospital, home, urban or rural deaths; age-, sex- and time-specific plausibility of specific diseases; stability and repeatability of dual physician coding; and the ability of the mortality classification system to capture a wide range of conditions. Results: The introduction of the MDS in India reduced the proportion of ill-defined deaths before age 70 years from 13% to 4%. The cause-specific mortality fractions (CSMFs) at ages 5 to 69 years for independently resampled deaths and the MDS were very similar across 19 disease categories. By contrast, CSMFs at these ages differed between hospital and home deaths and between urban and rural deaths. Thus, reliance mostly on urban or hospital data can distort national estimates of CODs. Age-, sex- and time-specific patterns for various diseases were plausible. Initial physician agreement on COD occurred about two-thirds of the time. The MDS COD classification system was able to capture more eligible records than alternative classification systems. By these metrics, the Indian MDS performs well for deaths prior to age 70 years. The key implication for low- and middle-income countries where medical certification of death remains uncommon is to implement COD surveys that randomly sample all deaths, use simple but high-quality field work with built-in resampling, and use electronic rather than paper systems to expedite field work and coding. Conclusions: Simple criteria can evaluate the performance of VA-based COD systems. Despite the misclassification of VA, the MDS demonstrates that national surveys of CODs using VA are an order of magnitude better than the limited COD data previously available.

6 March 2020 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
SMSharayu Mhatre
Sharayu Mhatre
PRPreetha Rajaraman
Preetha Rajaraman
NCNilanjan Chatterjee
Nilanjan Chatterjee
FBFreddie Bray
Freddie Bray
MGMahesh Goel
Mahesh Goel
RDRajesh Dikshit
Rajesh Dikshit